AVITA Medical (RCEL) Operating Income (2018 - 2025)

AVITA Medical has reported Operating Income for 8 years, with the latest figure at -$10.4 million in Q4 2025.

• For the quarter ending Q4 2025, Operating Income fell 130.92% year-over-year to -$10.4 million; the trailing twelve-month figure through Dec 2025 stood at -$42.5 million (down 227.81% YoY), and the FY2025 full-year result was -$42.5 million, down 227.79% from the prior year.
• Operating Income for Q4 2025 stood at -$10.4 million, down from -$9.2 million in the prior quarter.
• The five-year high for Operating Income was $33.7 million in Q4 2024, with the low at -$17.2 million in Q1 2024.
• Historically, Operating Income has averaged -$6.3 million across 5 years, with a median of -$9.7 million in 2022.
• Annual changes were most pronounced in 2023 — Operating Income tumbled 176.68% — and 2024, when it jumped 374.26%.
• AVITA Medical's Operating Income stood at -$5.9 million in 2021, then soared by 369.04% to $16.0 million in 2022, then plunged by 176.68% to -$12.3 million in 2023, then jumped by 374.26% to $33.7 million in 2024, then tumbled by 130.92% to -$10.4 million in 2025.
• The last three Operating Income figures came in at -$10.4 million (Q4 2025), -$9.2 million (Q3 2025), and -$11.1 million (Q2 2025), per Business Quant data.